A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact
Introduction: Inflammatory bowel disease activity is associated with adverse pregnancy outcomes. Anti-tumor necrosis factor α therapy is often required to treat flares and to maintain disease remission. However, there are concerns regarding treatment with these agents during pregnancy, as they activ...
Main Authors: | Joana Roseira, Jaime Ramos |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2019-04-01
|
Series: | Acta Médica Portuguesa |
Subjects: | |
Online Access: | https://actamedicaportuguesa.com/revista/index.php/amp/article/view/11482 |
Similar Items
-
Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
by: Darja Urlep, et al.
Published: (2013-10-01) -
Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease
by: Rocío Prieto-Pérez, et al.
Published: (2016-02-01) -
Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
by: Bruno Laganà, et al.
Published: (2019-01-01) -
Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy
by: Ana Esteve-Solé, et al.
Published: (2017-09-01) -
Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
by: Sherman Picardo, et al.
Published: (2020-06-01)